Lopez RD - Search Results

1

Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.

Liu Z, Guo BL, Gehrs BC, Nan L, Lopez RD. Liu Z, et al. Among authors: lopez rd. J Urol. 2005 May;173(5):1552-6. doi: 10.1097/01.ju.0000154355.45816.0b. J Urol. 2005. PMID: 15821484

2

Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12.

Guo BL, Hollmig KA, Lopez RD. Guo BL, et al. Among authors: lopez rd. Cancer Immunol Immunother. 2002 Jan;50(11):625-37. doi: 10.1007/s00262-001-0244-4. Epub 2001 Nov 15. Cancer Immunol Immunother. 2002. PMID: 11807626

3

Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.

Guo BL, Liu Z, Aldrich WA, Lopez RD. Guo BL, et al. Among authors: lopez rd. Breast Cancer Res Treat. 2005 Sep;93(2):169-75. doi: 10.1007/s10549-005-4792-8. Breast Cancer Res Treat. 2005. PMID: 16187237

4

Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer.

Liu Z, Eltoum IE, Guo B, Beck BH, Cloud GA, Lopez RD. Liu Z, et al. Among authors: lopez rd. J Immunol. 2008 May 1;180(9):6044-53. doi: 10.4049/jimmunol.180.9.6044. J Immunol. 2008. PMID: 18424725

5

Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.

Liu Z, Guo B, Lopez RD. Liu Z, et al. Among authors: lopez rd. J Gastroenterol Hepatol. 2009 May;24(5):900-11. doi: 10.1111/j.1440-1746.2008.05668.x. Epub 2008 Nov 3. J Gastroenterol Hepatol. 2009. PMID: 19175829

6

Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.

Beck BH, Kim HG, Kim H, Samuel S, Liu Z, Shrestha R, Haines H, Zinn K, Lopez RD. Beck BH, et al. Among authors: lopez rd. Breast Cancer Res Treat. 2010 Jul;122(1):135-44. doi: 10.1007/s10549-009-0527-6. Epub 2009 Sep 18. Breast Cancer Res Treat. 2010. PMID: 19763820 Free PMC article.

7

CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies.

Lopez RD, Xu S, Guo B, Negrin RS, Waller EK. Lopez RD, et al. Blood. 2000 Dec 1;96(12):3827-37. Blood. 2000. PMID: 11090067 Free article.

8

gammadelta T cells: a new frontier for immunotherapy?

Lamb LS Jr, Lopez RD. Lamb LS Jr, et al. Among authors: lopez rd. Biol Blood Marrow Transplant. 2005 Mar;11(3):161-8. doi: 10.1016/j.bbmt.2004.11.015. Biol Blood Marrow Transplant. 2005. PMID: 15744234 Free article. Review.

9

Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Lopez RD. Lopez RD. Immunol Res. 2002;26(1-3):207-21. doi: 10.1385/IR:26:1-3:207. Immunol Res. 2002. PMID: 12403359 Review.

10

Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.

Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, Lopez RD, Lamb LS Jr. Bryant NL, et al. Among authors: lopez rd. Neuro Oncol. 2009 Aug;11(4):357-67. doi: 10.1215/15228517-2008-111. Epub 2009 Feb 11. Neuro Oncol. 2009. PMID: 19211933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page